+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06649851

Phase 2 Study of G-CSF to Protect Brain Structure and Function After Standard Chemoradiation in Adults With Newly Diagnosed MGMT-Methylated Glioblastoma

Led by Massachusetts General Hospital · Updated on 2026-05-05

60

Participants Needed

1

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of granulocyte colony stimulating factor G-CSF in patients with newly diagnosed MGMT-methylated glioblastoma multiforme GBM who are receiving standard chemoradiation treatment. This phase II clinical study aims to assess how G-CSF affects brain structure, cognitive function, and overall brain health, as well as its safety and tolerability when combined with radiation and chemotherapy. The study drugs involved include G-CSF Filgrastim and temozolomide, a chemotherapy drug approved for GBM treatment. Participants will be randomly assigned to receive either standard chemoradiation alone or standard chemoradiation combined with G-CSF. The treatment begins with a 6-week cycle of radiation therapy combined with temozolomide, followed by a 4-week break during which G-CSF is given daily for 5 days. After the break, participants may receive up to 6 additional 4-week chemotherapy cycles with temozolomide, during which G-CSF is administered daily for 3 days each cycle. G-CSF is injected under the skin and can be given by study staff or self-administered after training. Participants will be involved in the study for up to 24 months, including screening, treatment, and follow-up visits. Brain MRI scans with contrast, neurocognitive tests, quality of life and mood assessments, and safety monitoring will be performed throughout. Researchers will measure adverse events, changes in brain volume, cognitive function, mood, survival, and progression-free survival. Follow-up continues for up to 12 months after treatment to monitor long-term outcomes.

CONDITIONS

Brief Title

G-CSF After Chemo-radiation in Patients With Glioblastoma

Research Team

J

Jorg Dietrich, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here